Hikma launches Midazolam in sodium chloride injection bags
The product is indicated for continuous intravenous infusion for sedation of intubated and mechanically ventilated adults and other situations.
Hikma is offering Midazolam 0.9% Sodium Chloride Injection bags in 50 mg/50 ml and 100 mg/100 ml doses.
[Read more: Hikma to acquire Custopharm]
The product is indicated for continuous intravenous infusion for sedation of intubated and mechanically ventilated adults, pediatric and neonatal patients as a component of anesthesia or during treatment in a critical care setting.
[Read more: Hikma intros Kloxxado]